Stay updated on Nivolumab and Talimogene in Pleural Effusion Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Talimogene in Pleural Effusion Clinical Trial page.

Latest updates to the Nivolumab and Talimogene in Pleural Effusion Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision metadata updated: added Revision: v3.3.4 and removed Revision: v3.3.3.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedAdded North Carolina under the new Locations section. Removed the HHS Vulnerability Disclosure item from the footer; page revision updated to v3.3.3.SummaryDifference0.2%

- Check51 days agoChange Detected- Added collaborator: C. R. Bard; removed collaborator: CareFusion. - Page revision updated to v3.3.2.SummaryDifference0.1%

- Check58 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.1; no changes to study data or page navigation.SummaryDifference0.1%

- Check66 days agoChange DetectedThe general funding-related operating status notice has been removed from the page, removing a warning that information may be out of date and that some website functions may not be processed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check80 days agoChange DetectedNo additions or deletions were detected on the page.SummaryDifference0.4%

Stay in the know with updates to Nivolumab and Talimogene in Pleural Effusion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Talimogene in Pleural Effusion Clinical Trial page.